Kimer Med Press Kit

Media Contacts: facebook | twitter | email

Download Press Kit

Images

About

Kimer Med is developing a broad-spectrum antiviral drug.

Our vision is the end of all viral diseases in humans, pets and livestock.

Previous research showed effectiveness against 15 viruses,
As well as against Influenza H1N1 in mice, and in 11 tissue types
Check out our forum
Article about us on fightaging.org
Interview on lifespan.io
Will VTose work on this virus?
How does VTose (DRACO) work?
Why now? Why us? Why "VTose"? How long? How Much?

Logos

Location

Nelson, New Zealand

Around the Web

About Kimer Med

Kimer Med is a pre-seed biotech start-up. We are raising capital to extend testing to SARS-CoV-2, and to work toward clinical trials.

9 Viruses

Examples of what nine different viruses look like.

Biology Laboratory

Scene in a typical biology laboratory.

Double-Stranded RNA

Our compound is triggered by attaching to long segments of double-stranded RNA, which is only produced by viruses.

Cats

Feline Infectious Peritonitis (FIP) is caused by a mutant strain of Feline Coronavirus (FCoV), which is 100% fatal in cats unless effectively treated.

In Vivo Testing

An important development goal is in vivo testing, normally in either mice or hamsters.

Pigs

Several viruses have been responsible for massive health problems in pigs, which have resulted in the culling of entire herds in China and elsewhere. It's also possible for some viruses to jump from pigs to humans (such as Swine Flu).

Well Plates

Well plates like this are used for in vitro testing of our compound's effectiveness and toxicity.

VTose

Our compound helps protect against viral infection and disease.

Cattle

Viral diseases affect livestock, too. Bovine Viral Diarrhea Virus (BVDV) alone causes economic losses of hundreds of millions of dollars.

Rick Kiessig

Rick Kiessig, Co-Founder. Rick has been an entrepreneur and software architect for more than 40 years. He has published research in areas as diverse as biology and satellite software, and has a background in biochemistry, organic chemistry and complex project management. He's written software that's flown to Mars three times and on several other near and deep space missions. He's the primary author of five patents, and has had a software-oriented book published. He owned and operated a small business in Silicon Valley for about 20 yrs, and has worked with about a dozen startups. Rick moved to New Zealand in 2006. His hobbies include ham radio and asteroid tracking.

Phil Oliver

Phil Oliver, Co-Founder. Phil has been a self-taught programmer and software architect/engineer for about 40 years, working on a wide variety of software projects, including many engineering related ones. He has a lifelong interest in science and engineering and earned a degree in Biomedical Engineering in 2012. He designed and created multiple historical research tools on American Indian history and the American Civil War which were very widely used and facilitated historical research which resulted in new book publications by various authors. He's seen the potential of DRACO (now VTose) for years and was disappointed that it never received the attention that it deserved, and is happy to finally be working to turn that potential into actual working reality.